Skip to main content

AI Speeds Search for Therapies That Fight Adenocarcinoma

title

Mount Sinai researchers are assessing a platform that can conduct in silico scans of millions of potential drugs each day to identify candidates for testing and validation. The goal is to facilitate the identification of safe, effective therapeutics for patients with invasive early-stage lung adenocarcinoma.

Learn More